JUVÉDERM® VOLUMA® With Lidocaine for Correction of Temple Hollowing in Chinese Population

* Participant must be 18 or over, at the time of signing the ICF * Participants seeking improvement of temple hollowing * Capable of giving signed informed consent which includes compliance with the requirements and restrictions listed in the ICF and in the protocol * Written informed consent from the participant has been obtained prior to any study-related procedures * Written documentation has been obtained in accordance with the relevant country and local privacy requirements, where applicable * Is able to complete effectiveness self-assessments without the use of glasses (contact lens use is acceptable if they will be used for all participant self-assessments)

* Temple hollowing due to trauma, congenital malformations, or lipodystrophy, either congenital or acquired * Has experienced trauma to the temple area within 6 months before enrollment or has residual deficiencies, deformities, or scarring * Temporal arteritis or history of temporal arteritis * Temporomandibular joint dysfunction or any other jaw issues * Recurrent temporal headaches such as temporal tendinitis migraine * Active or recurrent inflammation or infection in either eye * Tendency to develop hypertrophic scarring * Active autoimmune disease * History of anaphylaxis or allergy to lidocaine (or any amide-based anesthetics), HA products, or Streptococcal protein * Current cutaneous or mucosal inflammatory or infectious processes (e.g. acne, herpes), abscess, an unhealed wound, or a cancerous or precancerous lesion, above the subnasal * Prior facial reconstructive surgeries, facelift, or browlift as well as surgeries on the temple area (eg, biopsy) * Fat injection or permanent facial implants anywhere in the face * Semipermanent soft-tissue filler treatment in the temple or mid-face within 36 months before enrollment * Temporary dermal filler injections above the subnasale within 12 months before enrollment * Mesotherapy or cosmetic facial procedures above the subnasale within 6 months before enrollment (examples of mesotherapy or cosmetic facial procedures are laser, photomodulation, intense pulsed light, radio frequency, dermabrasion, moderate or greater depth chemical peel, or other ablative procedures. * Injections in the nasolabial fold are acceptable only if done at least 3 months prior to enrollment * Botulinum toxin treatment above the subnasale within 6 months before enrollment * Has braces or other orthodontics * Not eligible for this study if participants have begun using any new over the counter or prescription oral or tropical, anti-wrinkle products above the subnasale within 30 days before enrollment. Participants who have been on a regimen of such products for at least 30 days are eligible for the study if they intend to continue their regimen throughout the study * Is on a regimen of anti-coagulation therapy (eg, warfarin, clopidogrel) * Has tattoos, piercings, facial hair, or scars above and including the subnasale that would interfere with visual assessment of the temple * Females who are pregnant, nursing, or planning a pregnancy * Plans a significant weight change (more than 10% of body weight) during the study